Dark

PULM
Pulmatrix, Inc. Common Stock
stock NASDAQ

At Close

Oct 1, 2026 12:20:05 PM EDT

1.51USD-1.623%(-0.03)11,087

1.20Bid 1.83Ask 0.63Spread

Pre-market

Oct 2, 2026 9:27:30 AM EDT

1.57USD+1.948%(+0.03)100

After-hours

Sep 30, 2026 4:20:30 PM EDT

1.52USD-0.654%(-0.01)0

OverviewHistoricalExchangesShortsNews

Dec 17, 2021

04:31PM EST Pulmatrix Announces Closing of $6.75 Million Registered Direct Offering PR Newswire

Dec 15, 2021

08:05AM EST Pulmatrix Prices 6.745K Convertible Shares, Warrants To Buy Up To ~5.6M Shares For Gross Proceeds $6.75M Benzinga

08:01AM EST Pulmatrix Announces $6.75 Million Registered Direct Offering PR Newswire

Nov 16, 2021

10:14AM EST Pulmatrix Granted U.S. Patent Titled 'Monovalent metal cation dry powders for inhalation' Benzinga

Nov 10, 2021

06:30PM EST Pulmatrix Q3 EPS $(0.15) Up From $(0.31) YoY, Sales $1.07M Down From $4.37M YoY Benzinga

04:16PM EST Pulmatrix Reports Third Quarter 2021 Financial Results and Provides Business PR Newswire

Nov 9, 2021

11:50AM EST Pulmatrix Announces Resolution Of Contract Dispute With Cipla; Cipla Will Continue To Reimburse Pulmatrix For 50% Of Third Party Costs For Development Of Pulmazole Benzinga

09:12AM EST Pulmatrix Reports Resolution Of Contract Dispute With Cipla RTTNews

09:04AM EST Pulmatrix Announces Resolution of Contract Dispute with Cipla PR Newswire

Oct 29, 2021

06:14AM EDT The following are some of the stocks making big moves in Friday's pre-market trading (as of 05.45 A.M. EDT). RTTNews

Oct 12, 2021

08:13AM EDT The Daily Biotech Pulse: NRx Stitches COVID-19 Drug Partnership, Protara Gets Nod For Starting Bladder Cancer Study, IGM Moves Beyond Oncology Benzinga

Sep 22, 2021

12:57PM EDT Looking Into Pulmatrix's Return On Capital Employed Benzinga

Aug 23, 2021

04:23PM EDT Pulmatrix On Aug. 17, Got Notice Of Delisting Or Failure To Satisfy A Continued Listing Rule Or Standard From Nasdaq Benzinga

Aug 18, 2021

07:38AM EDT The Daily Biotech Pulse: AzurRx Jumps On Data, Agios' Regulatory Application For Mitapivat Accepted For Priority Review, FDA Nod For GlaxoSmithKline Benzinga

Aug 17, 2021

08:28AM EDT The Daily Biotech Pulse: Lilly Reorganizes Business Units In Neuroscience Focus, Helius Medical Spikes On Breakthrough Designation, Ra Medical Sells Dermatology Business Benzinga

Aug 10, 2021

09:14AM EDT Pulmatrix Q2 Net Loss $3.9 Mln Vs Loss Of $1.2 Mln Last Year RTTNews

09:11AM EDT Pulmatrix Q2 EPS $(0.07) Down From $(0.05) YoY, Sales $2.25M Down From $3.50M YoY Benzinga

09:10AM EDT Pulmatrix Reports Second Quarter 2021 Financial Results and Provides Business PR Newswire

07:55AM EDT The Daily Biotech Pulse: Arcturus Soars On COVID-19 Vaccine Updates, Merck's Keytruda On Track For More Label Expansions, Eliem Debuts Benzinga

Aug 5, 2021

08:08AM EDT The Daily Biotech Pulse: Merck Reports Positive Keytruda Readout, Moderna Slips Despite Q2 Beat, Bayer To Buy Vividion For Up To $2B, GlycoMimetics Gets New CEO Benzinga

Aug 4, 2021

07:52AM EDT The Daily Biotech Pulse: Pfizer's Positive Readout, NRx Strikes R&D Collaboration With Mannkind, Cerus & Invitae Jump On Earnings Benzinga

May 26, 2021

05:10PM EDT Pulmatrix Files For Mixed Shelf Of Up To $100M Benzinga

May 20, 2021

11:28AM EDT Pulmatrix Posts Application For U.S. Patent Titled 'ANTIFUNGAL FORMULATIONS FOR PULMONARY ADMINISTRATION COMPRISING ITRACONAZOLE' Benzinga

May 12, 2021

08:57AM EDT The Daily Biotech Pulse: Minerva, InflaRx Report Positive Data Readouts, Lucira COVID-19 Test Kit Available On Amazon, Decision Day For Heron Benzinga

May 11, 2021

04:55PM EDT Pulmatrix Q1 EPS $(0.09) Up From $(0.23) YoY, Sales $1.39M Down From $2.76M YoY Benzinga

04:35PM EDT Pulmatrix Reports First Quarter 2021 Financial Results and Provides Business PR Newswire

07:54AM EDT The Daily Biotech Pulse: FDA Authorizes Pfizer-BioNTech COVID-19 Vaccine For Adolescents, Lilly Strikes R&D Collaboration, Vaccine Stocks Novavax, Inovio Sink On Earnings Benzinga

May 7, 2021

07:40AM EDT The Daily Biotech Pulse: Split Verdict For Chemocentryx, NKarta-CRISPR In Cell Therapy Collaboration, Orphazyme's Clinical Trial Setback, 2 IPOs Benzinga

Apr 21, 2021

07:31AM EDT The Daily Biotech Pulse: Moderna To Supply Variant-Specific Vaccine To Israel, Roche's Diagnostics Business Comes to Rescue Benzinga

Apr 15, 2021

09:17AM EDT Pulmatrix Hosting Key Opinion Webinar On PUR3100 Therapy For Treatment Of Acute Migraine Benzinga

09:15AM EDT Pulmatrix Hosting Key Opinion Webinar on PUR3100 (Orally Inhaled DHE) Therapy PR Newswire

Apr 14, 2021

07:51AM EDT The Daily Biotech Pulse: Novavax CFO Departs, Zai Lab Inks Cancer Drug Collaboration, FDA Nod For Gilead Benzinga

Apr 13, 2021

08:33AM EDT 10 Biggest Price Target Changes For Tuesday Benzinga

06:24AM EDT HC Wainwright & Co. Maintains Buy on Pulmatrix, Lowers Price Target to $5 Benzinga

Apr 12, 2021

05:43PM EDT Pulmatrix Issues Press Release Correcting Info On Phase 2 Proof-Of-Concept Efficacy Study For Treatment Of AECOPD, Says Study Will Not Commence Until 2022 Benzinga

05:42PM EDT Corrected: Pulmatrix to Regain Full Rights to PUR1800 and Narrow Spectrum PR Newswire

12:52PM EDT Pulmatrix Stock Is Trading Lower After JNJ's Lung Cancer Initiative Terminates PUR1800 Licensing Pact Benzinga

09:16AM EDT Pulmatrix To Regain Full Rights To Its Narrow Spectrum Kinase Inhibitor Portfolio RTTNews

09:03AM EDT Pulmatrix to Regain Full Rights To PUR1800 And Narrow Spectrum Kinase Inhibitor Portfolio Following J&J Decision To Terminate License, Development And Commercialization Agreement Benzinga

09:03AM EDT Pulmatrix to Regain Full Rights to PUR1800 and Narrow Spectrum Kinase Inhibitor PR Newswire

Mar 23, 2021

09:06AM EDT Pulmatrix FY20 EPS $(0.67), Up From $(1.23) YoY Benzinga

09:05AM EDT Pulmatrix Reports 2020 Financial Results and Provides Business Update PR Newswire

Mar 4, 2021

09:16AM EST Pulmatrix Provides Pipeline And Business Update Benzinga

Feb 25, 2021

03:28PM EST Pulmatrix 13D Filing From FiveT Shows 0% Stake In Co. Benzinga

Feb 24, 2021

10:42AM EST CVI Investments Reports In 13G Filing A 6.2% Stake In Pulmatrix Benzinga

Feb 16, 2021

01:30PM EST Pulmatrix Announces Closing of $40 Million Registered Direct Offering PR Newswire

Feb 11, 2021

11:26AM EST Mid-Morning Market Update: RCM Technologies Shares Spike Higher, Even As Walt Disney Prepares to Announce Q1 Results Benzinga

12:34AM EST Pulmatrix Announces $40 Mln Registered Direct Offering Priced At-the-Market Under Nasdaq Rules RTTNews

12:26AM EST Pulmatrix Announces $40 Million Registered Direct Offering Priced At-the-Market PR Newswire

Nov 12, 2020

09:05AM EST Pulmatrix Q3 EPS $(0.31) Down From $(0.18) YoY Benzinga

09:03AM EST Pulmatrix Reports Third Quarter 2020 Financial Results and Business Updates PR Newswire

Oct 21, 2020

09:09AM EDT Pulmatrix Announces Marketing And Distribution Partner Sensory Cloud's Commercial Launch Of FEND RTTNews

09:03AM EDT Pulmatrix Announces Commercial Launch of FEND, an OTC Nasal Hygiene Product PR Newswire

09:03AM EDT Pulmatrix Announces Commercial Launch Of FEND OTC Nasal Hygiene Product Proven to Reduce Airborne Respiratory Droplets, With Partner Sensory Cloud Benzinga

Oct 20, 2020

12:01PM EDT UPDATE: US Patent And Trademark Office Abstract For Pulmatrix's 'Inhalable dry powders' Benzinga

Sep 30, 2020

09:22AM EDT Pulmatrix Announces Publication Demonstrating Reduction Of Bioaerosols With FEND RTTNews

08:34AM EDT Pulmatrix Highlights Publication Demonstrating Reduction Of Bioaerosols With FEND Nasal Hygiene Product Designed Benzinga

08:31AM EDT FEND, an OTC Nasal Hygiene Product Designed to Cleanse Airways of Airborne Particles PR Newswire

Sep 29, 2020

08:34AM EDT Pulmatrix Appoints Todd Bazemore To Board, Effective October 1, 2020 RTTNews

08:31AM EDT Pulmatrix Strengthens Board of Directors with Appointment of Todd Bazemore PR Newswire

Sep 23, 2020

02:28PM EDT Pulmatrix Granted Canadian Patent Titled 'DRY POWDER FORMULATIONS AND METHODS FOR TREATING PULMONARY DISEASES' Benzinga

Sep 22, 2020

08:36AM EDT Pulmatrix Reports Progress On Product Pipeline Benzinga

Aug 7, 2020

09:07AM EDT Pulmatrix Q2 EPS $(0.05) Up From $(0.41) YoY, Sales $3.50M Down From $4.82M YoY Benzinga

09:01AM EDT Pulmatrix Reports Q2 2020 Results and Business Updates PR Newswire